Commission Decision (EU) 2021/1125 of 8 July 2021 refusing to include the medicinal product subject to prescription Zinc-D-gluconate in the list of medicinal products that shall not bear the safety features referred to in Article 54, point (o), of Directive 2001/83/EC of the European Parliament and of the Council (Text with EEA relevance)

CELEX: 32021D1125
Document type: DEC
Sector: Legislation
Date of document: 2021-07-08
In force since: 2021-07-29
Status: In force
ELI: http://data.europa.eu/eli/dec/2021/1125/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1

The medicinal product subject to prescription Zinc-D-gluconate shall not be included in Annex I to Delegated Regulation (EU) 2016/161 and shall not be exempted from the requirement to bear the safety features referred to in Article 54, point (o), of Directive 2001/83/EC.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions